CME Institute Activities

Additional stories

The Surgeon General has urged policy changes and cultural shifts to better support the mental health of parents and caregivers.
New research explores how psilocybin therapy and escitalopram alter brain dynamics in different ways to treat depression.
This week, we expose racial differences in postpartum mood disorders, explore cannabis use and birth defects, and tardive dyskinesia.
NRx Pharmaceuticals is developing a pair of promising new treatments for bipolar depression and suicidal ideation.
Esmethadone showed mixed results in phase 3 trials with promising response and remission rates, especially in severe depression cases.
Emotional dysregulation is increasingly recognized as a key factor in post-traumatic stress disorder development and persistence.
New research maps the neural mechanisms behind different forms of love, revealing that each type activates distinct areas of the brain.
Stanford research shows that advanced brain imaging and AI can identify depression biotypes, enabling more effective treatment options.
Columbia University research explores interpersonal psychotherapy (IPT) as a new treatment for PTSD in military members, veterans, and their families.